Plexus (NASDAQ:PLXS) Issues Q2 2026 Earnings Guidance

Plexus (NASDAQ:PLXSGet Free Report) issued an update on its second quarter 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.800-1.950 for the period, compared to the consensus earnings per share estimate of 1.630. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion.

Wall Street Analyst Weigh In

PLXS has been the topic of several recent analyst reports. Wall Street Zen cut Plexus from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Plexus in a research report on Thursday, January 22nd. Sidoti cut shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a research report on Friday, October 24th. Benchmark increased their price target on Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Needham & Company LLC boosted their price objective on Plexus from $158.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $171.00.

Get Our Latest Stock Report on PLXS

Plexus Stock Up 7.5%

Shares of NASDAQ PLXS opened at $186.58 on Thursday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.77. Plexus has a one year low of $103.43 and a one year high of $186.47. The stock has a market capitalization of $4.99 billion, a PE ratio of 29.80 and a beta of 0.81. The business’s fifty day moving average price is $157.46 and its 200-day moving average price is $145.04.

Plexus (NASDAQ:PLXSGet Free Report) last released its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.01. Plexus had a return on equity of 12.77% and a net margin of 4.29%.The firm had revenue of $1.07 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same period in the prior year, the firm earned $1.73 EPS. The company’s revenue was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. On average, equities research analysts anticipate that Plexus will post 5.9 EPS for the current year.

Insider Activity

In other news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $143.47, for a total value of $71,735.00. Following the transaction, the director owned 7,665 shares in the company, valued at $1,099,697.55. This represents a 6.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Patrick John Jermain sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $143.53, for a total transaction of $287,060.00. Following the sale, the chief financial officer directly owned 16,961 shares of the company’s stock, valued at approximately $2,434,412.33. This represents a 10.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 9,674 shares of company stock worth $1,382,876. Company insiders own 1.78% of the company’s stock.

Key Headlines Impacting Plexus

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Q1 results showed revenue of $1.07B (?+10% YoY) and non?GAAP EPS of $1.78, modestly beating estimates — evidence of demand strength across Healthcare/Life Sciences and Aerospace/Defense. Plexus Announces Fiscal First Quarter Financial Results
  • Positive Sentiment: Management issued stronger-than-expected Q2 fiscal 2026 guidance: non?GAAP EPS $1.80–$1.95 (vs. consensus ~1.63) and revenue $1.110–$1.150B, implying sequential acceleration — a key bullish catalyst. Quiver Quant Summary
  • Positive Sentiment: Company won 22 new manufacturing programs with $283M of annualized revenue potential (Aerospace/Defense accounted for a record $220M), supporting medium-term revenue ramps and market-share gains. Press Release
  • Neutral Sentiment: Board continued buybacks — $22.4M repurchased in Q1 at an avg $146.36, with ~$62.6M remaining under the $100M program (capital return supportive but modest). Press Release
  • Neutral Sentiment: Street reaction tempered by the fact the EPS beat was only $0.01 and reported revenue was essentially in line with expectations — upside is more about guidance than a large miss/beat. MSN recap
  • Negative Sentiment: GAAP diluted EPS fell to $1.51 from $1.87 the prior quarter and free cash flow was negative $50.6M due to working?capital investments and program ramps — a short?term liquidity/earnings headwind to monitor. Press Release
  • Negative Sentiment: Insider selling activity has been heavy in recent months (multiple executive sales reported), which can raise governance/market?perception concerns even if for tax/liquidity reasons. Quiver Quant insider summary

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in PLXS. Johnson Financial Group Inc. bought a new stake in Plexus during the 3rd quarter valued at $72,000. EverSource Wealth Advisors LLC lifted its stake in shares of Plexus by 583.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after purchasing an additional 490 shares during the last quarter. Corient Private Wealth LLC bought a new stake in Plexus during the second quarter valued at about $210,000. United Services Automobile Association purchased a new position in Plexus in the first quarter valued at about $218,000. Finally, Blair William & Co. IL bought a new position in Plexus in the third quarter worth about $259,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Stories

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.